Brainsway launches trial evaluating accelerated Deep TMS for depression
PremiumThe FlyBrainsway launches trial evaluating accelerated Deep TMS for depression
2M ago
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression
PremiumPress Releases
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression
2M ago
Brainsway receives expanded FDA labeling to treat late life depression
PremiumThe Fly
Brainsway receives expanded FDA labeling to treat late life depression
2M ago
Brainsway expands Deep TMS access in Israel
PremiumThe FlyBrainsway expands Deep TMS access in Israel
3M ago
Brainsway announces published review results on potential of Deep TMS
PremiumThe Fly
Brainsway announces published review results on potential of Deep TMS
4M ago
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson’s Disease
PremiumPress Releases
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson’s Disease
4M ago
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
PremiumPress ReleasesBrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights
5M ago
Brainsway reports Q4 EPS 0c vs 12c last year
PremiumThe Fly
Brainsway reports Q4 EPS 0c vs 12c last year
5M ago
BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
PremiumPress Releases
BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100